VIGABATRIN suppliers

VIGABATRIN

CAS:: 60643-86-9

MF:: C6H11NO2

MW:: 129.16

Use：: Hepatic impairment No dose adjustment is required for patients with hepatic impairment. Renal impairment Consider reducing maintenance dose or frequency of administration. Pregnancy Based on data on pregnancies exposed to vigabatrin, no definite conclusion can be drawn as to whether vigabatrin produces an increased risk of malformation when taken during pregnancy because of limited data and the administration of concomitant AEDs. Vigabatrin should not be used during pregnancy unless it is required based on the clinical condition of the patient. In such cases, the dose of vigabatrin should be monitored carefully during pregnancy and after birth, and adjustments made on a clinical basis. Vigabatrin is excreted in human milk: since there is insufficient information on the effects of vigabatrin in newborns/ infants, the possibility of avoiding breast- feeding should be considered.

More▼

You can find VIGABATRIN suppliers, manufacturers, and distributors from countries such as China, India and the United States here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.

Anhui Ruihan Technology Co., Ltd